diazobenzenesulfonic acid has been researched along with dasatinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ame, S; Bouchet, S; Cayssials, E; Charbonnier, A; Chomel, JC; Coiteux, V; Cony-Makhoul, P; Courby, S; Dubruille, V; Escoffre-Barbe, M; Etienne, G; Giraudier, S; Guerci-Bresler, A; Guilhot, F; Guilhot, J; Hermet, E; Huguet, F; Ianotto, JC; Johnson-Ansah, H; Legros, L; Lenain, P; Machet, A; Mahon, FX; Nicolini, FE; Rea, D; Rousselot, P; Roy, L | 1 |
1 trial(s) available for diazobenzenesulfonic acid and dasatinib
| Article | Year |
|---|---|
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).
Topics: Aged; Dasatinib; Humans; Interferon-alpha; Leukemia, Myeloid, Chronic-Phase; Polyethylene Glycols; Treatment Outcome | 2023 |